Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2001

01-05-2001

Smoking and Hematolymphopoietic Malignancies

Authors: E. Stagnaro, V. Ramazzotti, P. Crosignani, A. Fontana, G. Masala, L. Miligi, O. Nanni, M. Neri, S. Rodella, A. Seniori Costantini, R. Tumino, C. Viganò, C. Vindigni, P. Vineis

Published in: Cancer Causes & Control | Issue 4/2001

Login to get access
Metadata
Title
Smoking and Hematolymphopoietic Malignancies
Authors
E. Stagnaro
V. Ramazzotti
P. Crosignani
A. Fontana
G. Masala
L. Miligi
O. Nanni
M. Neri
S. Rodella
A. Seniori Costantini
R. Tumino
C. Viganò
C. Vindigni
P. Vineis
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1011216102871

Other articles of this Issue 4/2001

Cancer Causes & Control 4/2001 Go to the issue

OriginalPaper

Evaluating the Impact of Population Changes in Diet, Physical Activity, and Weight Status on Population Risk for Colon Cancer (United States)

OriginalPaper

The Heterogeneity in Risk Factors of Lung Cancer and the Difference of Histologic Distribution between Genders in Taiwan

OriginalPaper

Variants of the VDR gene and Risk of Colon Cancer (United States)

OriginalPaper

A Pooled Analysis of Case–Control Studies of Thyroid Cancer. VI. Fish and Shellfish Consumption

OriginalPaper

Pet Ownership and Childhood Acute Leukemia (USA and Canada)

OriginalPaper

Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits